As of September 1st, Otto Drakenberg, the current Chairman of CarpoNovum, will also assume the role of CEO of the company. This move will streamline governance and fully align the organization behind a strengthened and highly skilled clinical team, committed to delivering our clinical strategy.
Current CEO Pär-Ola Larsson will take on the role of Vice CEO as of 1 September until he leaves for an assignment in another medical device company during the fall. We wish him good luck in his future endeavours and thank him for his contribution.
Comments